Lobbying Filing Details

Total Spending

$1,220,000

Activities

5

Lobbyists

5

Gov't Entities

40

Filing Information
Filing UUID:
2ac2a05d-5f6d-4caa-a4bc-fca9a2cb09e4
Type:
Q2 - 2nd Quarter - Report
Period:
2020 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2020 at 8:02 PM
Income:
$0
Expenses:
$1,220,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Elizabeth Hall
Registrant
ELEVANCE HEALTH, INC.

Health Benefits Company

Washington, District of Columbia
Client
ELEVANCE HEALTH, INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Financial Institutions/Investments/Securities

Coronavirus Aid, Relief, and Economic Security (CARES) Act
COVID-19 Legislation (Phase I, II, III and other)
Commercial paper market stability
COBRA Subsidies
Federal Medical Assistance Percentages (FMAP) increase
Special enrollment period
State and local funding support
COVID-19 testing, vaccinations, cost sharing for COVID-19 testing

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Treasury, Dept of
  • ... and 3 more
Activity 2
Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization, (H.R. 3107)
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630)
Price of prescription drugs
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; (H.R. 3)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895)
COVID-19 legislation (Phase I, II, III and other); Commercial paper market stability; Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act; SEPs; Risk Mitigation and Excess Loss; COBRA; Coverage Mandates
Federal Medical Assistance Percentages (FMAP) increase

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Treasury, Dept of
  • ... and 3 more
Activity 3
Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization, (H.R. 3107)
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630)
Price of prescription drugs
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; (H.R. 3)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895)
COVID-19 legislation (Phase I, II, III and other); Commercial paper market stability; Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act; SEPs; Risk Mitigation and Excess Loss; COBRA; Coverage Mandates
Federal Medical Assistance Percentages (FMAP) increase

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Treasury, Dept of
  • ... and 3 more
Activity 4
Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members,
reauthorization of special need plans, star ratings, normalization factors, stars contract
consolidation, ESRD, audio-only telehealth)
Medicare RAD-V
Mental health and substance use (42 CFR Part 2)
Medicaid managed care (MIND Act) (H.R. 6926) (IMD Exclusion)
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Social Determents of Health (SDOH)
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Medicare Part D crosswalk policy
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicaid non-emergency medical transportation
Medicare Advantage Pilot Program in TRICARE
Maternal Health Quality Improvement Act (H.R. 4995)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Drug Price Transparency in Medicaid Act of 2019 (H.R. 5281)
Non Emergency Medical Transportation (The Protecting Patients Transportation to Care Act)(S.2846)
Medicaid maternal health coverage expansion (H.R.6800)

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Treasury, Dept of
  • ... and 3 more
Activity 5
Pharmacy

Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; HR 3
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,Lower Health Care Cost Act of 2019 (S. 1895), (H.R. 5304)

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Treasury, Dept of
  • ... and 3 more

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.